INSIGHTS ON CRITICAL ENVIRONMENTS
-
503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance
Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.
-
Your Global Partner In Pharmaceutical Contamination Control
Ensure cleanroom compliance with an expert team that helps you interpret critical data, align with global regulations, and maintain control through proactive contamination strategies.
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Maintaining A State Of Control: EM And DES In Biopharma
Partner with a proven team to streamline your facility validation and environmental monitoring programs with flexible, cGMP-compliant services and reliable on-site collection.
-
A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings9/2/2026
Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.
-
Microbial Air Sampling: Easy, Efficient, And Operator Error-Resistant9/8/2025
Streamline microbial air sampling with an innovative, portable solution that enhances efficiency, reduces errors, and supports compliance in controlled environments through advanced data management.
-
Risked-based Cleaning Validation Process Checklist6/19/2025
Is your cleaning validation process truly aligned with current regulatory expectations? This checklist helps you implement a risk-based approach, focusing resources to effectively mitigate your highest-risk areas.
-
Meet Regulation Requirements With RTU Vials And Cartridges10/9/2025
Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.
-
Confessions Of A Microbiologist: What I Wish I Had Known For Our Facility Shutdown11/17/2025
Facility shutdowns often compromise contamination control strategies. Transitioning from manual cleaning to automated bio-decontamination ensures a more effective facility restart, eliminating persistent mold risks.
CRITICAL ENVIRONMENT SOLUTIONS
-
Modernize oligonucleotide manufacturing with robust filtration systems built for hazardous environments. Enhance purity and speed across every batch to ensure reliable and scalable production.
-
Your next drug manufacturing cleanroom is more akin to a piece of equipment than a room. Operational efficiencies, compliant flow of materials and personnel, and lifecycle considerations should dictate the selection of your cleanroom partner. AES designers have been engineering functional cleanroom facilities for over three decades, guaranteeing the performance of each and every facility. Our in-house designers work as a team with our cleanroom construction personnel to engineer a cost-effective project while maximizing performance, value, and constructability. The greatest value is realized when AES is integrated into the design team at the start of the project. Early project integration with the AES experts helps the infrastructure team decide what support and cleanroom solutions the clean space requires. Early participation by AES saves design costs, expedites schedule, and eliminates a duplication of services.
-
Used Kiefel Technologies Bag Making Machine, Model KIF 52, Serial #416-030, for forming, filling, and sealing medical-grade bags and IV bags.
-
The AES modular cleanroom system is engineered with inherent flexibility to seamlessly incorporate essential modular cleanroom accessories while maintaining structural integrity and eliminating the need for costly engineering rework.
-
AES utilizes a cross-functional project team from design through commissioning. This multi-discipline approach is dedicated to delivering a compliant facility. AES has strict quality, cost, and schedule expectations. The AES team is comprised of experienced personnel who have a full understanding of how to construct in a GMP environment and how to seamlessly transition a facility toward operational readiness.
FREE CLEANING VALIDATION E-BOOK
Learn how to employ science-, risk-, and statistics-based approaches to cleaning and cleaning validation at your facility with this free, 100-page e-book, written by a global team of cleaning validation experts, pharmaceutical toxicologists, statisticians, and Six Sigma professionals.
